Intercure (INCR) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Intercure (INCR) has outperformed Stablecoin Development (SDEV) over the past year, losing 38.5% versus a loss of 76.1%. Over five years, INCR leads with a -85.4% price change compared with -100.0% for SDEV. Stablecoin Development is the larger company by market cap ($79.7 million vs $77.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INCR | SDEV |
|---|---|---|
| Share price | $5.17 | $1.54 |
| Market cap | $77.57M | $79.70M |
| 1-day change | +2.99% | -22.61% |
| YTD return | +13.63% | -94.54% |
| 1-year return | -38.45% | -76.12% |
| 5-year return | -85.42% | -99.95% |
| EPS (TTM) | $-0.95 | $-16.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.32 | $99.75 |
| 52-week low | $3.40 | $0.78 |
| Distance from 52-week high | -37.86% | -98.46% |
| Average volume | 22.06K | 11.93M |
| Shares outstanding | 15.00M | 51.75M |
| Employees | 285 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INCR has outperformed SDEV by 37.7 percentage points over the past year.
About Intercure
INCR stock →InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Health Care · Biotechnology: Pharmaceutical Preparations · 285 employees
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
INCR vs SDEV FAQ
Which is bigger, Intercure or Stablecoin Development?
Stablecoin Development (SDEV) is larger, with a market capitalization of $79.70M compared with $77.57M for Intercure (INCR).
Which stock has performed better over the past year, INCR or SDEV?
INCR returned -38.45% over the past 12 months, compared with -76.12% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are Intercure and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.